Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer

Author: Ecke Thorsten H.   Huang-Tiel Hui-Juan   Golka Klaus   Selinski Silvia   Geis Berit Christine   Koswig Stephan   Bathe Katrin   Hallmann Steffen   Gerullis Holger  

Publisher: MDPI

E-ISSN: 1422-0067|17|11|1879-1879

ISSN: 1422-0067

Source: International Journal of Molecular Sciences, Vol.17, Iss.11, 2016-11, pp. : 1879-1879

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content